0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Human Papillomavirus (HPV) Vaccines - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-28A7224
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Papillomavirus HPV Vaccines Market Insights and Forecast to 2028
BUY CHAPTERS

Human Papillomavirus (HPV) Vaccines - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-28A7224
Report
November 2023
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Papillomavirus (HPV) Vaccines - Market Size

The global Human Papillomavirus (HPV) Vaccines market size is expected to reach US$ 27200 million by 2029, growing at a CAGR of 5.9% from 2023 to 2029.

Human Papillomavirus (HPV) Vaccines -  Market

Human Papillomavirus (HPV) Vaccines - Market

The market is mainly driven by the significant applications of Human Papillomavirus (HPV) Vaccines in various end use industries. The expanding demands from the Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies and Others,, are propelling Human Papillomavirus (HPV) Vaccines market. 2-Valent Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 4-Valent Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Papillomavirus (HPV) Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Human Papillomavirus (HPV) Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Papillomavirus (HPV) Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Papillomavirus (HPV) Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Papillomavirus (HPV) Vaccines covered in this report include Merck, GSK and Walvax, etc.
The global Human Papillomavirus (HPV) Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
GSK
Walvax

Scope of Human Papillomavirus (HPV) Vaccines - Market Report

Report Metric Details
Report Name Human Papillomavirus (HPV) Vaccines - Market
Forecasted market size in 2029 US$ 27200 million
CAGR 5.9%
Forecasted years 2023 - 2029
Global Human Papillomavirus (HPV) Vaccines market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Papillomavirus (HPV) Vaccines market, Segment by Type:
  • 2-Valent Vaccine
  • 4-Valent Vaccine
Global Human Papillomavirus (HPV) Vaccines market, by Application
  • Research & Academic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Human Papillomavirus (HPV) Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Human Papillomavirus (HPV) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What is the Human Papillomavirus (HPV) Vaccines - Market size in 2029?

Ans: The Human Papillomavirus (HPV) Vaccines - Market size in 2029 will be US$ 27200 million.

What are the Application segmentation covered in the Human Papillomavirus (HPV) Vaccines - Market report?

Ans: The Applications covered in the Human Papillomavirus (HPV) Vaccines - Market report are Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others

What are the Type segmentation covered in the Human Papillomavirus (HPV) Vaccines - Market report?

Ans: The Types covered in the Human Papillomavirus (HPV) Vaccines - Market report are 2-Valent Vaccine, 4-Valent Vaccine

1 Human Papillomavirus (HPV) Vaccines Market Overview
1.1 Human Papillomavirus (HPV) Vaccines Product Overview
1.2 Human Papillomavirus (HPV) Vaccines Market Segment by Type
1.2.1 2-Valent Vaccine
1.2.2 4-Valent Vaccine
1.3 Global Human Papillomavirus (HPV) Vaccines Market Size by Type
1.3.1 Global Human Papillomavirus (HPV) Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Human Papillomavirus (HPV) Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Papillomavirus (HPV) Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Papillomavirus (HPV) Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Papillomavirus (HPV) Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Breakdown by Type (2018-2023)
2 Global Human Papillomavirus (HPV) Vaccines Market Competition by Company
2.1 Global Top Players by Human Papillomavirus (HPV) Vaccines Sales (2018-2023)
2.2 Global Top Players by Human Papillomavirus (HPV) Vaccines Revenue (2018-2023)
2.3 Global Top Players by Human Papillomavirus (HPV) Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Human Papillomavirus (HPV) Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Papillomavirus (HPV) Vaccines Market Competitive Situation and Trends
2.5.1 Human Papillomavirus (HPV) Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Papillomavirus (HPV) Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Human Papillomavirus (HPV) Vaccines Market
2.8 Key Manufacturers Human Papillomavirus (HPV) Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Papillomavirus (HPV) Vaccines Status and Outlook by Region
3.1 Global Human Papillomavirus (HPV) Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Papillomavirus (HPV) Vaccines Historic Market Size by Region
3.2.1 Global Human Papillomavirus (HPV) Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Human Papillomavirus (HPV) Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Human Papillomavirus (HPV) Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Region
3.3.1 Global Human Papillomavirus (HPV) Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Human Papillomavirus (HPV) Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Human Papillomavirus (HPV) Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Papillomavirus (HPV) Vaccines by Application
4.1 Human Papillomavirus (HPV) Vaccines Market Segment by Application
4.1.1 Research & Academic Laboratories
4.1.2 Pharmaceutical & Biotechnology Companies
4.1.3 Others
4.2 Global Human Papillomavirus (HPV) Vaccines Market Size by Application
4.2.1 Global Human Papillomavirus (HPV) Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Human Papillomavirus (HPV) Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Papillomavirus (HPV) Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Papillomavirus (HPV) Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Papillomavirus (HPV) Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Breakdown by Application (2018-2023)
5 North America Human Papillomavirus (HPV) Vaccines by Country
5.1 North America Human Papillomavirus (HPV) Vaccines Historic Market Size by Country
5.1.1 North America Human Papillomavirus (HPV) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2018-2023)
5.2 North America Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Country
5.2.1 North America Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2024-2029)
6 Europe Human Papillomavirus (HPV) Vaccines by Country
6.1 Europe Human Papillomavirus (HPV) Vaccines Historic Market Size by Country
6.1.1 Europe Human Papillomavirus (HPV) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Country
6.2.1 Europe Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Papillomavirus (HPV) Vaccines by Region
7.1 Asia-Pacific Human Papillomavirus (HPV) Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Human Papillomavirus (HPV) Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales in Value by Region (2024-2029)
8 Latin America Human Papillomavirus (HPV) Vaccines by Country
8.1 Latin America Human Papillomavirus (HPV) Vaccines Historic Market Size by Country
8.1.1 Latin America Human Papillomavirus (HPV) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Country
8.2.1 Latin America Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Papillomavirus (HPV) Vaccines by Country
9.1 Middle East and Africa Human Papillomavirus (HPV) Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Human Papillomavirus (HPV) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Papillomavirus (HPV) Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Human Papillomavirus (HPV) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Human Papillomavirus (HPV) Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Human Papillomavirus (HPV) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 GSK Human Papillomavirus (HPV) Vaccines Products Offered
10.2.5 GSK Recent Development
10.3 Walvax
10.3.1 Walvax Company Information
10.3.2 Walvax Introduction and Business Overview
10.3.3 Walvax Human Papillomavirus (HPV) Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Walvax Human Papillomavirus (HPV) Vaccines Products Offered
10.3.5 Walvax Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Papillomavirus (HPV) Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Papillomavirus (HPV) Vaccines Industrial Chain Analysis
11.4 Human Papillomavirus (HPV) Vaccines Market Dynamics
11.4.1 Human Papillomavirus (HPV) Vaccines Industry Trends
11.4.2 Human Papillomavirus (HPV) Vaccines Market Drivers
11.4.3 Human Papillomavirus (HPV) Vaccines Market Challenges
11.4.4 Human Papillomavirus (HPV) Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Papillomavirus (HPV) Vaccines Distributors
12.3 Human Papillomavirus (HPV) Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of 2-Valent Vaccine
    Table 2. Major Company of 4-Valent Vaccine
    Table 3. Global Human Papillomavirus (HPV) Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 4. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (K Units)
    Table 5. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type (2018-2023)
    Table 6. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (US& Million)
    Table 7. Global Human Papillomavirus (HPV) Vaccines Market Share in Value by Type (2018-2023)
    Table 8. Global Human Papillomavirus (HPV) Vaccines Price by Type (2018-2023) & (USD/Unit)
    Table 9. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2024-2029) & (K Units)
    Table 10. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type (2024-2029)
    Table 11. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2024-2029) & (US$ Million)
    Table 12. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Type (2024-2029)
    Table 13. Global Human Papillomavirus (HPV) Vaccines Price by Type (2024-2029) & (USD/Unit)
    Table 14. North America Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (K Units)
    Table 15. North America Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 16. Europe Human Papillomavirus (HPV) Vaccines Sales (K Units) by Type (2018-2023)
    Table 17. Europe Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 18. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales (K Units) by Type (2018-2023)
    Table 19. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 20. Latin America Human Papillomavirus (HPV) Vaccines Sales (K Units) by Type (2018-2023)
    Table 21. Latin America Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 22. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales (K Units) by Type (2018-2023)
    Table 23. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2023) & (US$ Million)
    Table 24. Global Human Papillomavirus (HPV) Vaccines Sales by Company (2018-2023) & (K Units)
    Table 25. Global Human Papillomavirus (HPV) Vaccines Sales Share by Company (2018-2023)
    Table 26. Global Human Papillomavirus (HPV) Vaccines Revenue by Company (2018-2023) & (US$ Million)
    Table 27. Global Human Papillomavirus (HPV) Vaccines Revenue Share by Company (2018-2023)
    Table 28. Global Market Human Papillomavirus (HPV) Vaccines Price by Company (2018-2023) & (USD/Unit)
    Table 29. Global Human Papillomavirus (HPV) Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 30. Global Human Papillomavirus (HPV) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Papillomavirus (HPV) Vaccines as of 2022)
    Table 32. Date of Key Manufacturers Enter into Human Papillomavirus (HPV) Vaccines Market
    Table 33. Key Manufacturers Human Papillomavirus (HPV) Vaccines Product Type
    Table 34. Mergers & Acquisitions, Expansion Plans
    Table 35. Global Human Papillomavirus (HPV) Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Global Human Papillomavirus (HPV) Vaccines Sales by Region (2018-2023) & (K Units)
    Table 37. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 38. Global Human Papillomavirus (HPV) Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 39. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 40. Global Human Papillomavirus (HPV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 41. Global Human Papillomavirus (HPV) Vaccines Sales by Region (2024-2029) & (K Units)
    Table 42. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 43. Global Human Papillomavirus (HPV) Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 44. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 45. Global Human Papillomavirus (HPV) Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 46. Global Human Papillomavirus (HPV) Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 47. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (K Units)
    Table 48. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Application (2018-2023)
    Table 49. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 50. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application (2018-2023)
    Table 51. Global Human Papillomavirus (HPV) Vaccines Price by Application (2018-2023) & (USD/Unit)
    Table 52. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2024-2029) & (K Units)
    Table 53. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Application (2024-2029)
    Table 54. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2024-2029) & (US$ Million)
    Table 55. Global Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application (2024-2029)
    Table 56. Global Human Papillomavirus (HPV) Vaccines Price by Application (2024-2029) & (USD/Unit)
    Table 57. North America Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) (K Units)
    Table 58. North America Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 59. Europe Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) (K Units)
    Table 60. Europe Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 61. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) (K Units)
    Table 62. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 63. Latin America Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) (K Units)
    Table 64. Latin America Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 65. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) (K Units)
    Table 66. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2023) & (US$ Million)
    Table 67. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 68. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 69. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 70. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 71. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 72. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 73. North America Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 74. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 75. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 76. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 77. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 78. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 79. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 80. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 81. Europe Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 82. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 83. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Region (2018-2023) & (K Units)
    Table 84. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Region (2018-2023)
    Table 85. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Region (2018-2023) & (US$ Million)
    Table 86. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Region (2018-2023)
    Table 87. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Region (2024-2029) & (K Units)
    Table 88. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Region (2024-2029)
    Table 89. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales by Region (2024-2029) & (US$ Million)
    Table 90. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Region (2024-2029)
    Table 91. Latin America Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 92. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 93. Latin America Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 94. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 95. Latin America Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 96. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 97. Latin America Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 98. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 99. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (K Units)
    Table 100. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2018-2023)
    Table 101. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2018-2023) & (US$ Million)
    Table 102. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2018-2023)
    Table 103. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (K Units)
    Table 104. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Country (2024-2029)
    Table 105. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales by Country (2024-2029) & (US$ Million)
    Table 106. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Country (2024-2029)
    Table 107. Merck Company Information
    Table 108. Merck Introduction and Business Overview
    Table 109. Merck Human Papillomavirus (HPV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 110. Merck Human Papillomavirus (HPV) Vaccines Product
    Table 111. Merck Recent Development
    Table 112. GSK Company Information
    Table 113. GSK Introduction and Business Overview
    Table 114. GSK Human Papillomavirus (HPV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 115. GSK Human Papillomavirus (HPV) Vaccines Product
    Table 116. GSK Recent Development
    Table 117. Walvax Company Information
    Table 118. Walvax Introduction and Business Overview
    Table 119. Walvax Human Papillomavirus (HPV) Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 120. Walvax Human Papillomavirus (HPV) Vaccines Product
    Table 121. Walvax Recent Development
    Table 122. Key Raw Materials Lists
    Table 123. Raw Materials Key Suppliers Lists
    Table 124. Human Papillomavirus (HPV) Vaccines Market Trends
    Table 125. Human Papillomavirus (HPV) Vaccines Market Drivers
    Table 126. Human Papillomavirus (HPV) Vaccines Market Challenges
    Table 127. Human Papillomavirus (HPV) Vaccines Market Restraints
    Table 128. Human Papillomavirus (HPV) Vaccines Distributors List
    Table 129. Human Papillomavirus (HPV) Vaccines Downstream Customers
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Papillomavirus (HPV) Vaccines Product Picture
    Figure 2. Global Human Papillomavirus (HPV) Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Human Papillomavirus (HPV) Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Human Papillomavirus (HPV) Vaccines Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of 2-Valent Vaccine
    Figure 6. Global 2-Valent Vaccine Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of 4-Valent Vaccine
    Figure 8. Global 4-Valent Vaccine Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Global Human Papillomavirus (HPV) Vaccines Sales by Type (2018-2029) & (US$ Million)
    Figure 10. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Type in 2022 & 2029
    Figure 11. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 12. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Type in 2022
    Figure 13. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 14. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Type in 2022
    Figure 15. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 16. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Type in 2022
    Figure 17. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 18. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Type in 2022
    Figure 19. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Type in 2022
    Figure 20. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Type in 2022
    Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papillomavirus (HPV) Vaccines Sales in 2022
    Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Papillomavirus (HPV) Vaccines Revenue in 2022
    Figure 23. Human Papillomavirus (HPV) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 24. Product Picture of Research & Academic Laboratories
    Figure 25. Global Research & Academic Laboratories Sales YoY Growth (2018-2029) & (K Units)
    Figure 26. Product Picture of Pharmaceutical & Biotechnology Companies
    Figure 27. Global Pharmaceutical & Biotechnology Companies Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of Others
    Figure 29. Global Others Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Global Human Papillomavirus (HPV) Vaccines Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Human Papillomavirus (HPV) Vaccines Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 33. North America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application in 2022
    Figure 34. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Human Papillomavirus (HPV) Vaccines Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Human Papillomavirus (HPV) Vaccines Manufacturing Cost Structure
    Figure 43. Human Papillomavirus (HPV) Vaccines Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS